- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
HYPE3
SAO
Week ended 07 Aug 2026
Weekly Investor Report
Hypera S.A. · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
21.60 BRL
1.6%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -2.8% below the Trend Line and sits at 24.5% of its 52-week range. The latest completed week returned 1.6%, after a 2.3% four-week move. The latest news-sentiment score is 48/100.
Setup score
37
out of 100
Latest Close
21.60 BRL
7 Aug 2026
1W Return
1.6%
latest completed week
4W Return
2.3%
short-term follow-through
12W Return
-5.1%
quarterly tape
Trend Breadth
19.2%
10 of 52 weeks active
Volume Ratio
1.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.6%
Latest completed week; four-week move 2.3%.
Indicator stack
11/43
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
48/100
7 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -2.8% below the Trend Line and sits at 24.5% of its 52-week range. The latest completed week returned 1.6%, after a 2.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1012-week average 0.07
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure1/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.10Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.3% over four weeks, -5.1% over 12 weeks, and -3.4% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year10
Trend breadth19.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.61Latest activity-pressure read.
Pressure change45.8%Four-week change in activity pressure.
Leadership-8.52Latest relative-leadership reading.
RS change47.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment48/100
Weighted news tone is neutral across 7 relevant articles.
1 positive · 5 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-20.4%Distance below the 52-week high.
13-week volatility3.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+6.7%Week of 26 Jun.
Worst week-5.9%Week of 19 Jun.
Latest week+1.6%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains10
Flat weeks0
Modest losses9
Sharp losses4
Recent vol3.6%13-week weekly-return volatility.
Base vol4.0%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew3.5% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorBR Healthcare
4-week rank26 / 82
Group average-0.7%
Trend breadth35.4%
Trend35.4%active weekly trend signals
MD65.9%positive activity pressure
RS46.3%positive relative leadership
Four-week leaders
IndustryBR Drug Manufacturers - Specialty & Generic
4-week rank2 / 9
Group average-2.9%
Trend breadth22.2%
Trend22.2%active weekly trend signals
MD33.3%positive activity pressure
RS44.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape33/100
Trend, activity pressure, participation, and risk combine to a 33/100 tape read.
Indicator analysis12/100Latest 12-week confirmation: trend 0/12, activity pressure 1/12, relative leadership 0/12.
Activity pressure 0.10; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment48/100Weighted news tone is neutral across 7 relevant articles.
Transcript : Hypera S.A., Q2 2025 Earnings Call, Aug 07, 2025 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 21.60 BRL | 1.6% | 22.23 BRL | 24.60 BRL | -0.61 | -8.52 | 13.2M | Off |
| 31 Jul 2026 | 21.27 BRL | 5.1% | 22.28 BRL | 24.71 BRL | -0.94 | -13.17 | 12.5M | Off |
| 24 Jul 2026 | 20.23 BRL | -4.5% | 22.34 BRL | 24.83 BRL | -1.13 | -16.35 | 23.0M | Off |
| 17 Jul 2026 | 21.19 BRL | 0.4% | 22.43 BRL | 24.95 BRL | -1.06 | -13.09 | 10.6M | Off |
| 10 Jul 2026 | 21.11 BRL | 0.6% | 22.47 BRL | 25.07 BRL | -1.12 | -16.23 | 11.8M | Off |
| 3 Jul 2026 | 20.99 BRL | -1.5% | 22.53 BRL | 25.18 BRL | -1.05 | -15.82 | 1.4M | Off |
| 26 Jun 2026 | 21.31 BRL | 6.7% | 22.66 BRL | 25.31 BRL | -1.07 | -14.85 | 2.8M | Off |
| 19 Jun 2026 | 19.97 BRL | -5.9% | 22.82 BRL | 25.43 BRL | -1.04 | -18.66 | 3.1M | Off |
| 12 Jun 2026 | 21.23 BRL | 2.4% | 22.97 BRL | 25.55 BRL | -0.76 | -15.66 | 1.6M | Off |
| 5 Jun 2026 | 20.72 BRL | -4.2% | 23.10 BRL | 25.67 BRL | -0.42 | -17.38 | 3.3M | Off |
| 29 May 2026 | 21.64 BRL | -2.9% | 23.22 BRL | 25.79 BRL | -0.04 | -16.72 | 8.4M | Off |
| 22 May 2026 | 22.28 BRL | -2.0% | 23.34 BRL | 25.89 BRL | 0.02 | -16.00 | 11.1M | Off |
| 15 May 2026 | 22.75 BRL | -1.4% | 23.36 BRL | 25.98 BRL | -0.07 | -15.23 | 33.1M | Off |
| 8 May 2026 | 23.08 BRL | 3.7% | 23.32 BRL | 26.05 BRL | -0.16 | -17.65 | 29.9M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.